Race and family history assessment for breast cancer

Journal of General Internal Medicine

Volumn 20, Issue 1, 2005, Pages 75-80

  Murff, Harvey J ^a,b   Byrne, Daniel ^a   Haas, Jennifer S ^c   Puopolo, Ann Louise ^c   Brennan, Troyen A ^c,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast neoplasm; Communication; Family history; Medical interviewing; Racial disparities

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER SCREENING; CAUCASIAN; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PATIENT CARE; PRIMARY MEDICAL CARE; RACE; RACE DIFFERENCE; SELF REPORT; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MEDICAL HISTORY TAKING; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 13944264245     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.40112.x     Document Type: Article

References (62)

1. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 1997;71:800-9.
2. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet. 1997;71:315-24.
3. Johnson N, Lancaster T, Fuller A, Hodgson SV. The prevalence of a family history of cancer in general practice. Fam Pract. 1995;12:287-9.
4. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA. 1993; 270:1563-8.
5. Colditz GA, Willett WC, Hunter DJ, et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA. 1993;270:338-43.
6. U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137(pt 1):344-6.
7. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst. 1997;89:1015-26.
8. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003;53:141-69.
9. Shattuck-Eidens D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA. 1997;278:1242-50.
10. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-54.
11. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88:114-23.
12. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128:729-36.
13. O'Malley MS, Earp JA, Hawley ST, Schell MJ, Mathews HF, Mitchell J. The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening? Am J Public Health. 2001;91:49-54.
14. Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev. 1999;23:463-73.
15. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-12.
16. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-91.
17. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93:1704-13.
18. Shinagawa SM. The excess burden of breast carcinoma in minority and medically underserved communities: application, research, and redressing institutional racism. Cancer. 2000;88(suppl): 1217-23.
19. Earp JA, Eng E, O'Malley MS, et al. Increasing use of mammography among older, rural African American women: results from a community trial. Am J Public Health. 2002;92:646-54.
20. Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20:1260-8.
21. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159-64.
22. Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol. 2001;19:924-30.
23. Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet. 2003;361:296-300.
24. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77-84.
25. Armstrong K, Weber B, Stopfer J, et al. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Am J Med Genet. 2003:117A:154-60.
26. Emery J, Rose P. Expanding the role of the family history in primary care. Br J Gen Pract. 1999;49:260-1; Editorial.
27. Fry A, Campbell H, Gudmunsdottir H, et al. GPs' views on their role in cancer genetics services and current practice. Fam Pract. 1999;16: 468-74.
28. Ashton CM, Haidet P, Paterniti DA, et al. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? J Gen Intern Med. 2003;18:146-52.
29. Bickell NA. Race, ethnicity, and disparities in breast cancer: victories and challenges. Womens Health Issues. 2002;12:238-51.
30. Haas JS, Cleary PD, Puopolo AL, Burstin HR, Cook EF, Brennan TA. Differences in the professional satisfaction of general internists in academically affiliated practices in the greater-Boston area. Ambulatory Medicine Quality Improvement Project Investigators. J Gen Intern Med. 1998;13:127-30.
31. Haas JS, Cook EF, Puopolo AL, Burstin HR, Brennan TA. Differences in the quality of care for women with an abnormal mammogram or breast complaint. J Gen Intern Med. 2000;15:321-8.
32. Haas JS, Cook EF, Puopolo AL, Burstin HR, Cleary PD, Brennan TA. Is the professional satisfaction of general internists associated with patient satisfaction? J Gen Intern Med. 2000;15:122-8.
33. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15:149-54.
34. Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics. 1994;50:270-8.
35. Acheson L, Wiesner G, Zyzanski S, Goodwin M, Strange K. Family history-taking in community family practice: implications for genetic screening. Genet Med. 2000;2:180-5.
36. Mayberry RM, Stoddard-Wright C. Breast cancer risk factors among black women and while women: similarities and differences. Am J Epidemiol. 1992;136:1445-56.
37. Hall IJ, Burke W, Coughlin S, Lee NC. Population-based estimates of the prevalence of family history of cancer among women. Community Genet. 2001;4:134-42.
38. Natarajan N, Nemoto T, Mettlin C, Murphy GP. Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer. 1985; 56:1704-9.
39. Bondy ML, Spitz MR, Halabi S, Fueger JJ, Vogel VG. Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control. 1992;3:377-82.
40. Blumenthal D, Causino N, Chang YC, et al. The duration of ambulatory visits to physicians. J Fam Pract. 1999;48:264-71.
41. Summerton N, Garrood PV. The family history in family practice: a questionnaire study. Fam Pract. 1997;14:285-8.
42. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer. 1998;82:1197-207.
43. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31-48.
44. Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst. 2003;95:478-83.
45. Brinton LA, Benichou J, Gammon MD, Brogan DR, Coates R, Schoen-berg JB. Ethnicity and variation in breast cancer incidence. Int J Cancer. 1997;73:349-55.
46. Althuis MD, Brogan DD, Coates RJ, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003;14:151-60.
47. Hofman KJ, Tambor ES, Chase GA, Geller G, Faden RR, Holtzman NA. Physicians' knowledge of genetics and genetic tests. Acad Med. 1993;68:625-32.
48. Watson BK, Shickie D, Qureshi N, Emery J, Austoker J. The 'new genetics' and primary care: GPs' views on their role and their educational needs. Fam Pract. 1999;16:420-5.
49. Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract. 1999;16:426-45.
50. Hunter A, Wright P, Cappelli M, Kasaboski A, Surh L. Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet. 1998;53:447-55.
51. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997;336:1409-15.
52. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 1994;73:643-51.
53. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-86.
54. Olopade OI, Fackenthal JD, Dunston G, Talnsky MA, Collins F, Whitfleld-Broome C. Breast cancer genetics in African Americans. Cancer. 2003;97(Suppl):236-45.
55. Gao Q, Neuhausen S, Cummings S, Luce M, Olopade OI. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet. 1997;60:1233-6.
56. Hyland F, Kinmonth AL, Marteau TM, et al. Raising concerns about family history of breast cancer in primary care consultations: prospective, population based study. Women's Concerns Study Group. BMJ. 2001;322:27-8.
57. Anton-Culver H, Kurosaki T, Taylor TH, Gildea M, Brunner D, Bringman D. Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. Genet Epidemiol. 1996;13:193-205.
58. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol. 1997;146:244-8.
59. Parent ME, Ghadirian P, Lacroix A, Perret C. The reliability of recollections of family history: implications for the medical provider. J Cancer Educ. 1997;12:114-20.
60. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev. 1994;3: 321-7.
61. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282: 583-9.
62. Schmittdiel J, Grumbach K, Selby JV, Quesenberry CP Jr. Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. J Gen Intern Med. 2000;15:761-9.